FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Solomon Jonathan Eitan

 2. Date of Event Requiring Statement (MM/DD/YYYY)
10/28/2019 

 3. Issuer Name and Ticker or Trading Symbol

BiomX Inc. [PHGE]

(Last)        (First)        (Middle)

C/O BIOMX LTD., 7 PINHAS SAPIR ST., FLOOR 2

 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Chief Executive Officer /

(Street)

NESS ZIONA, L3 7414002      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)

 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Common Stock Options - Right to Buy  (1)1/7/2027 Common Stock Options 167434 $0.54 D  
Common Stock Options - Right to Buy  (2)3/26/2027 Common Stock Options 182133 $1.69 D  
Common Stock Options - Right to Buy  (3)5/22/2028 Common Stock Options 201718 $1.97 D  
Common Stock Options - Right to Buy  (4)3/29/2029 Common Stock Options 284701 $2.03 D  
Explanation of Responses:
(1) 20% of these options vested upon Mr. Solomon's appointment as Chief Executive Officer of BiomX Ltd., a wholly-owned subsidiary of the Issuer, in February 2017. Of the remaining 80%, 25% vested on February 1, 2017, with the remaining options vesting in 12 equal quarterly installments over three years. As of the reporting date, options to purchase 52,316 shares of common stock were unvested.
(2) 25% of these options vested on March 26, 2018. Thereafter, the remaining options shall vest in 12 equal quarterly installments over three years. As of the reporting date, options to purchase 68,301 shares of common stock were unvested.
(3) 25% of these options vested on May 22, 2019. Thereafter, the remaining options shall vest in 12 equal quarterly installments over three years. As of the reporting date, options to purchase 138,682 shares of common stock were unvested.
(4) 25% of these options shall vest on March 29, 2020. Thereafter, the remaining options shall vest in 12 equal quarterly installments over three years. As of the reporting date, options to purchase 284,701 shares of common stock were unvested.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Solomon Jonathan Eitan
C/O BIOMX LTD.
7 PINHAS SAPIR ST., FLOOR 2
NESS ZIONA, L3 7414002		X
Chief Executive Officer
Signatures
/s/ Jonathan Solomon11/5/2019
**Signature of Reporting PersonDate
Chardan Healthcare Acqui... (AMEX:CHAC)
Historical Stock Chart
Von Apr 2024 bis Mai 2024 Click Here for more Chardan Healthcare Acqui... Charts.
Chardan Healthcare Acqui... (AMEX:CHAC)
Historical Stock Chart
Von Mai 2023 bis Mai 2024 Click Here for more Chardan Healthcare Acqui... Charts.